Lineup announced for May 16-18 pharmaceutical convention

Magid Abou-GharbiaMoulder, from the Temple University School of Pharmacy, will present
Magid Abou-GharbiaMoulder, from the Temple University School of Pharmacy, will present "Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision." | File photo

The biggest pharmaceutical event series in the world, the CPhl, will take place May 16-18 in Philadelphia and feature over 55 speakers.

Ronald Piervincenzi, CEO of United States Pharmacopeial Convention (USP), will present "Partnering for Quallity: A New Era," in which he will share his insights on how to create higher quality in medicines around the world.

Magid Abou-GharbiaMoulder, from the Temple University School of Pharmacy, will present "Discovery of Innovative Therapeutics: Today's Realities and Tomorrow's Vision." The session will focus on challenges that face the pharmaceutical industry, from the competition of generics to mergers and the bad reputation that parts of the industry have come to suffer from.

"Attendees will advance their understanding of pharmaceutical industry efforts to address the major challenges they and our healthcare system are facing, while continuing the industry's commitment to innovation, reducing costs and benefiting patients," Abou-GharbiaMoulder said.

The CPhl Connect Conference Program also will feature key speakers from Merck, Massachusetts Institute of Technology, Bristol-Myers Squibb, AbbVie, Eli Lilly Co., and more.